Full details, including potential risk factors, are given in the Press Release, which can be consulted by clicking on the link below
Eyelid Application of NCX 4251 for Treatment of Signs and Symptoms of Dry Eye Disease

May 4, 2022

View Press Release Corporate presentation Contact us
Previous